Top news coverage from the NFID 19th Annual Conference on Vaccine Research on April 18-20, 2016 in Baltimore, MD:
- Experts focus on vaccines to combat antimicrobial resistance (Healio Infectious Disease News)
Featuring Bruce G. Gellin, MD, MPH, National Vaccine Program Office, US Department of Health and Human Services
- Findings support development of staphylococcal enterotoxin B protein vaccine (Healio Infectious Disease News)
Featuring Wilber Chen, MD, University of Maryland School of Medicine
- Flublok demonstrates superior efficacy over IIV (Healio Infectious Disease News)
Featuring Lisa M. Dunkle, MD, Protein Sciences Corp.
-
Hope for Zika Vaccine Stems from Precedent (History of Vaccines)
- HPV vaccination increases among teens with health-seeking behaviors (Healio Infectious Diseases in Children)
Featuring Holly B. Fontenot, PhD, RN, NP, William F. Connell School of Nursing at Boston College
- HSV-2 vaccine candidate reduces viral shedding, genital lesions up to 1 year (Healio Infectious Disease News)
Featuring Seth Hetherington, MD, Genocea Biosciences
-
Lessons Learned from Ebola Virus Vaccine Trials (History of Vaccines)
- Limited knowledge about Zika poses challenge in vaccine development (Healio Infectious Disease News)
Featuring Col. Paul B. Keiser, MD, Walter Reed Army Institute of Research
- New approaches needed to address vaccine resistance (Healio Infectious Disease News)
Featuring Gregory A. Poland, MD, Vaccine Research Group at the Mayo Clinic
- Recent progress in development of universal flu vaccine (Healio Infectious Disease News)
Featuring Peter Palese, PhD, Icahn School of Medicine at Mount Sinai
- Third phase 3 trial shows HEPLISAV-B vaccine safe, effective against HBV (Healio Infectious Disease News)
Featuring Sam Jackson, MD, investigator for Dynavax Technologies
- William Schaffner, MD, discusses ACVR highlights (Healio Infectious Disease News)
Featuring William Schaffner, MD, Medical Director, National Foundation for Infectious Diseases, Infectious Disease News Editorial Board member
Limited copies of the 2016 ACVR Program Book including extended abstracts and speaker bios are available for purchase. Download the Program Book Order Form to order copies.
Planning is now underway for the 20th Annual Conference on Vaccine Research in April 2017 in Bethesda, MD. To receive updates about upcoming conferences and events, subscribe to NFID Updates.
To join the conversation, follow us on Twitter (@nfidvaccines) using the hashtag #ACVR, like us on Facebook, join the NFID Linkedin Group, and subscribe to NFID Updates.
